ZOM In The News – Zomedica Stock is Off To a Rough Start Today

Zomedica Pharmaceutical by First American News LLC

First American News LLC, Raleigh NC: following the war in Ukraine, some stocks are off to a bad start this Monday. Zomedica closed last Friday at $0.35 down 3.32% from previous close at $0.36.

Zomedica News – ZOM reported its last quarter earnings this past Friday and it

announced revenues and gross margin for the Fourth Quarter and Full Year 2021.

Total revenue for the Fourth Quarter and Full Year 2021 was $4.1 million, compared to $0 in both periods in 2020. Gross margin was 73.9%. Zomedica ended the year with cash and cash equivalents on hand of $195 million.

PulseVet revenue grew to $4.0 million in the Fourth Quarter 2021, an increase of 66% over its Fourth Quarter 2020 revenue of $2.4 million as a standalone company.

Save 77% off with our Top Subscription Deals by First American News

TRUFORMA® product revenue grew to $73,000 in the Fourth Quarter 2021, an increase of 224% over its Third Quarter 2021 revenue of $22,500.

Zomedica’s Form 10-K for 2021 and its full Fourth Quarter and Full Year 2021 Earnings Release, will be issued on March 1, 2022.